Markets
GSK

Sector Update: Health Care

Healthcare stocks were slightly higher today with the NYSE Healthcare Sector Index climbing about 0.1% and shares of healthcare companies in the S&P 500 also adding about 0.1% as a group.

In company news, Amicus Therapeutics Inc. ( FOLD ) rose to a new 52-week high Wednesday after reporting positive 18-month data from a second Phase III trial of its oral small molecule chaperone migalastat HCl in patients with Fabry disease and amenable mutations.

Shares were up over 11% at $3.77 each in late trade, backing down from its new year-to-date high of $6.46 a share.

(+) PTX, Acquires all of GlaxoSmithKline's ( GSK ) rights to Treximet migraine treatment after securing necessary financing. Agrees to continue GSK's current product developments efforts with Pozen ( POZN ) and undertake certain new activities.

(-) NBY, Said its NVC-422 ophthalmic drug candidate did not meet primary or secondary endpoints during Phase II study in patients with adenoviral conjunctivitis.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GSK FOLD

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More